Literature DB >> 7116240

Flash electroretinogram abnormalities in patients with clinically definite multiple sclerosis.

S G Coupland, T H Kirkham.   

Abstract

We studied the flash electroretinograms (ERGs) of 105 patients with multiple sclerosis who were divided into four groups. The first group had no history or clinical evidence of optic nerve dysfunction, the second and third groups had either left or right optic nerve disease respectively, and the fourth group had historical or clinical evidence of bilateral optic nerve disease. Statistical analysis of the data using analysis of variance (ANOVA) showed that the group of patients with no history or clinical evidence of optic nerve disease had no significant difference from the control group for their peak b-wave implicit times but the other three groups were significantly delayed on the affected side(s). Using the Mann-Whitney U-test we found all four patient groups had significantly greater absolute interocular latency differences from the control group. The electroretinal contribution to flash VEP delay was also investigated. In those patients with unilateral or bilateral optic nerve disease we found that in 14-31% of those patients with flash VEP delay there was also abnormal prolongation of the ERG b-wave. These results confirm a high incidence of retinal dysfunction in multiple sclerosis patients and may suggest that transynaptic degeneration of retinal structures occurs in optic nerve demyelination. The significant absolute interocular latency difference in particular may provide another electrophysiological parameter to establish a diagnosis of multiple sclerosis in suspect cases.

Entities:  

Mesh:

Year:  1982        PMID: 7116240     DOI: 10.1017/s0317167100044152

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  6 in total

1.  Electroretinographic abnormalities in multiple sclerosis: possible role for retinal autoantibodies.

Authors:  Farzin Forooghian; Melanie Sproule; Carol Westall; Lynn Gordon; Guy Jirawuthiworavong; Kaori Shimazaki; Paul O'Connor
Journal:  Doc Ophthalmol       Date:  2006-09-14       Impact factor: 2.379

2.  Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration.

Authors:  Ari J Green; Stephen McQuaid; Stephen L Hauser; Ingrid V Allen; Roy Lyness
Journal:  Brain       Date:  2010-04-21       Impact factor: 13.501

3.  Enolase autoantibodies and retinal function in multiple sclerosis patients.

Authors:  Farzin Forooghian; Grazyna Adamus; Melanie Sproule; Carol Westall; Paul O'Connor
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08       Impact factor: 3.535

4.  Progressive inner nuclear layer dysfunction in non-optic neuritis eyes in MS.

Authors:  Yuyi You; Elizabeth C Graham; Ting Shen; Con Yiannikas; John Parratt; Vivek Gupta; Joshua Barton; Michael Dwyer; Michael H Barnett; Clare L Fraser; Stuart L Graham; Alexander Klistorner
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-12-15

5.  Color vision versus pattern visual evoked potentials in the assessment of subclinical optic pathway involvement in multiple sclerosis.

Authors:  Fatih C Gundogan; Ahmet Tas; Salih Altun; Oguzhan Oz; Uzeyir Erdem; Gungor Sobaci
Journal:  Indian J Ophthalmol       Date:  2013-03       Impact factor: 1.848

Review 6.  Leveraging Visual Outcome Measures to Advance Therapy Development in Neuroimmunologic Disorders.

Authors:  Jennifer S Graves; Frederike Cosima Oertel; Anneke Van der Walt; Sara Collorone; Elias S Sotirchos; Gorm Pihl-Jensen; Philipp Albrecht; E Ann Yeh; Shiv Saidha; Jette Frederiksen; Scott Douglas Newsome; Friedemann Paul
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-12-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.